Skip to content

Lexicon Pharmaceuticals LXRX Investment Purchases

Investment Purchases at other companies

Eli Lilly logo
Eli LillyLLY
$297M+50.8%
Merck & Co. logo
Merck & Co.MRK
$374M-37.1%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$2.51B+52.2%
Cytokinetics logo
CytokineticsCYTK
$106.52M-33.1%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$58.3M+692%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$43.41M+2,106%

Other financials

Income statement

See full
Revenue$21.1M+1,572%
Gross profit$21.0M+1,604%
Operating income-$996.0K+96.1%
Net income-$1.0M+95.9%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$67.1M+6.7%
Total debt$57.7M-45.7%
Total equity$202.9M+64.9%
Total assets$268.8M-9.7%

Cash flow

See full
Operating cash flow-$14.7M+66.4%
CapEx--100%
Free cash flow-$17.2M+21.5%

Valuation

See full
Market cap$1.02B+273%
Enterprise value$1.01B+219%
P/S14.6×+5.9×

Profitability

See full
Gross margin99.5%+1.5pp
Operating margin-34.8%-16.8pp
Net margin-37.5%-18.1pp
FCF margin-578.5%-283pp

Returns & leverage

See full
Return on equity-16%-7.2pp
Debt / equity0.3×-0.6×
Current ratio18.8×+16.6×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.

The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lexicon Pharmaceuticals's investment purchases?
Lexicon Pharmaceuticals (LXRX) reported investment purchases of $105.96M in Q1 2026.
How has Lexicon Pharmaceuticals's investment purchases changed year-over-year?
Lexicon Pharmaceuticals's investment purchases increased by 63.1% year-over-year, from $64.97M to $105.96M.
What is the long-term trend for Lexicon Pharmaceuticals's investment purchases?
Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's investment purchases has grown at a 42.1% compound annual growth rate (CAGR), from $34.26M to $139.84M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.